Hong, Siting
Zhu, Xiang-Yang
Jiang, Yamei
Zhang, Lei
Tang, Hui
Jordan, Kyra L.
Saadiq, Ishran M.
Huang, Weijun
Lerman, Amir
Eirin, Alfonso
Lerman, Lilach O. http://orcid.org/0000-0002-3271-3887
Funding for this research was provided by:
National Institutes of Health (DK120292, DK122734, HL158691, AG062104)
Article History
Accepted: 20 October 2022
First Online: 7 November 2022
Declarations
:
: The study was approved by the Mayo Clinical Animal Care and Use Committee (A65014-15).
: Not applicable.
: All authors have read and agreed to the published version of the manuscript.
: LOL is an advisor to AstraZeneca, Butterfly Biosciences, CureSpec, Beren Therapeutics, and Ribocure Pharmaceuticals. The other authors indicated no potential conflicts of interest.